Home / Funds / Voleon Capital Management LP
Voleon Capital Management LP
The short positions this fund discloses today, across every market.
8 open positions
4 Markets
July 21, 2026 Last disclosure
549300EJ1ZB4YYIOMD56 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Zealand Pharma A/S | Denmark | 1.11% | May 19, 2026 |
| B&M European Value Retail S.A. | Germany | 0.79% | April 20, 2026 |
| Oryzon Genomics, S.A. | Spain | 0.63% | July 3, 2026 |
| Gubra A/S | Denmark | 0.59% | March 23, 2026 |
| Lang & Schwarz Aktiengesellschaft | Germany | 0.59% | February 2, 2022 |
| Tubacex, S.A. | Spain | 0.59% | June 30, 2026 |
| Medigene AG | Germany | 0.55% | December 4, 2017 |
| Atos Group | France | 0.50% | July 21, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| April 29, 2021 | Eurotech SPA | Italy | 1.17% | still open |
| April 28, 2021 | Solutions 30 SE | France | 0.54% | October 22, 2021 |
| April 28, 2021 | Gensight Biologics S.A. | France | 0.49% | April 30, 2021 |
| April 28, 2021 | Cell Impact AB (publ) | Sweden | 0.00% | still open |
| April 27, 2021 | Juventus Football Club SPA | Italy | 0.50% | still open |
| April 26, 2021 | Quantum Genomics | France | 0.99% | June 14, 2021 |
| April 26, 2021 | Cell Impact AB (publ) | Sweden | 0.58% | still open |
| April 26, 2021 | Gensight Biologics S.A. | France | 0.50% | April 30, 2021 |
| April 26, 2021 | Solutions 30 SE | France | 0.49% | April 28, 2021 |
| April 22, 2021 | Erytech Pharma | France | 0.80% | still open |
| April 22, 2021 | Phaxiam Therapeutics | France | 0.80% | May 20, 2021 |
| April 20, 2021 | Eurotech SPA | Italy | 1.26% | still open |
| April 20, 2021 | Biophytis | France | 0.91% | June 18, 2021 |
| April 20, 2021 | Cell Impact AB (publ) | Sweden | 0.69% | still open |
| April 19, 2021 | Eurotech SPA | Italy | 1.34% | still open |
| April 19, 2021 | Biophytis | France | 0.83% | June 18, 2021 |
| April 19, 2021 | Metabolic Explorer | France | 0.48% | April 21, 2021 |
| April 16, 2021 | Erytech Pharma | France | 0.71% | still open |
| April 16, 2021 | Phaxiam Therapeutics | France | 0.71% | May 20, 2021 |
| April 16, 2021 | Duro Felguera, S.A. | Spain | 0.59% | still open |
| April 16, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.49% | still open |
| April 16, 2021 | Immunovia AB (publ) | Sweden | 0.00% | still open |
| April 15, 2021 | Quantum Genomics | France | 1.08% | June 14, 2021 |
| April 15, 2021 | Cell Impact AB (publ) | Sweden | 0.79% | still open |
| April 15, 2021 | Metabolic Explorer | France | 0.51% | April 21, 2021 |
| April 14, 2021 | Cell Impact AB (publ) | Sweden | 0.83% | still open |
| April 14, 2021 | Duro Felguera, S.A. | Spain | 0.69% | still open |
| April 14, 2021 | Immunovia AB (publ) | Sweden | 0.59% | still open |
| April 13, 2021 | Navya | France | 0.95% | August 3, 2021 |
| April 13, 2021 | Cell Impact AB (publ) | Sweden | 0.91% | still open |
| April 13, 2021 | Duro Felguera, S.A. | Spain | 0.72% | still open |
| April 13, 2021 | Biophytis | France | 0.70% | June 18, 2021 |
| April 13, 2021 | Erytech Pharma | France | 0.61% | still open |
| April 13, 2021 | Phaxiam Therapeutics | France | 0.61% | May 20, 2021 |
| April 13, 2021 | Metabolic Explorer | France | 0.49% | April 15, 2021 |
| April 13, 2021 | Solocal Group | France | 0.45% | April 15, 2021 |
| April 12, 2021 | Navya | France | 1.16% | August 3, 2021 |
| April 12, 2021 | Biophytis | France | 0.89% | June 18, 2021 |
| April 12, 2021 | Immunovia AB (publ) | Sweden | 0.67% | still open |
| April 9, 2021 | Metro Bank PLC | United Kingdom | 0.59% | still open |
| April 9, 2021 | Solutions 30 SE | France | 0.50% | April 28, 2021 |
| April 8, 2021 | Navya | France | 1.39% | August 3, 2021 |
| April 8, 2021 | Biophytis | France | 0.97% | June 18, 2021 |
| April 8, 2021 | Erytech Pharma | France | 0.50% | still open |
| April 8, 2021 | Phaxiam Therapeutics | France | 0.50% | May 20, 2021 |
| April 7, 2021 | Eurotech SPA | Italy | 1.49% | still open |
| April 7, 2021 | Cell Impact AB (publ) | Sweden | 1.07% | still open |
| April 7, 2021 | Solocal Group | France | 0.57% | April 15, 2021 |
| April 7, 2021 | 4D Pharma PLC | United Kingdom | 0.42% | still open |
| April 7, 2021 | Oncopeptides AB | Sweden | 0.00% | still open |
The funds short on the same companies
- Citadel Advisors LLC 2 companies in common
- AHL Partners LLP 1 company in common
- ActusRayPartners Limited 1 company in common
- Capital Fund Management 1 company in common
- Citadel Advisors II LLC 1 company in common
- Connor Clark & Lunn Investment Management Ltd 1 company in common
- D. E. Shaw & Co., L.P. 1 company in common
- GSA Capital Partners LLP 1 company in common
- Jennison Associates LLC 1 company in common
- Jupiter Asset Management Limited 1 company in common
- Marshall Wace LLP 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=62